Skip to Content
Return to Navigation

COVID-19 Vaccine Candidate Heads To Widespread Testing In U.S.-NPR

The COVID-19 vaccine candidate made by the U.S. biotech company Moderna and developed in collaboration with the National Institutes of Health starts its final phase of testing Monday. This phase is called Phase 3 efficacy testing, and it is designed to see if the vaccine actually prevents disease. NPR, 07/27/2020

Share this article: